Clinical Trial Update: Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence [NA]

View source ↗

Summary

A clinical trial update on hyperthermic intraperitoneal chemotherapy (HIPEC) for first recurrence of ovarian cancer; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: First Recurrence of Ovarian Cancer | NA | Status: UNKNOWN